TickerFacts.

Company research / ELAN

Elanco Animal Health Inc (ELAN)

Build a valuation ↗↓ Download CSV

CIK 0001739104 · NYSE · Pharmaceutical Preparations

  • Sector Manufacturing
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Elanco Animal Health Inc reported revenue of $4.71B. Revenue grew 6.2% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $5.02B.

Key ratios (year ended 2025-12-31)

55.0%
Gross margin
-4.9%
Net margin
-3.5%
Return on year-end equity
6.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-10-19

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$5.02B$4.71B$4.44B$4.42B$4.41B$4.76B$3.27B$3.07B$3.07B$2.89B$2.91B
Cost of Revenue$2.24B$2.12B$2.00B$1.93B$1.91B$2.13B$1.67B$1.47B$1.57B$1.49B$1.41B
Gross Profit$2.78B$2.59B$2.44B$2.49B$2.50B$2.63B$1.61B$1.60B$1.49B$1.40B$1.50B
R&D Expense$371.00M$368.00M$344.00M$327.00M$321.00M$369.00M$329.00M$270.00M$246.60M$251.70M$265.80M
Depreciation & Amortization$693.00M$680.00M$662.00M$694.00M$682.00M$716.00M$517.00M$314.00M$296.00M$318.40M$254.40M
Net Income-$199.00M-$232.00M$338.00M-$1.23B-$78.00M-$483.00M-$574.00M$68.00M$86.50M-$310.70M-$47.90M
EPS (Diluted)n/a-$0.47$0.68-$2.50-$0.16-$0.99-$1.30$0.18$0.28-$1.06n/a
Total Assets$13.56B$13.36B$12.61B$14.36B$15.49B$16.48B$17.69B$8.99B$8.96B$8.94Bn/a
Total Liabilities$6.97B$6.81B$6.52B$8.14B$8.20B$8.97B$9.22B$3.44B$3.76B$1.16Bn/a
Long-Term Debt$3.66B$3.76B$4.32B$5.77B$5.84B$6.32B$6.13B$2.35B$2.47Bn/an/a
Shareholders' Equity$6.59B$6.55B$6.10B$6.22B$7.29B$7.51B$8.46B$5.55B$5.20B$7.78B$7.02B
Cash & Equivalents$530.00M$545.00M$468.00M$352.00M$345.00M$638.00M$495.00M$334.00M$474.80M$323.40Mn/a
Operating Cash Flow$617.00M$560.00M$541.00M$271.00M$452.00M$483.00M-$41.00M$224.00M$487.30M$173.80M$155.90M
Capital Expenditures$238.00M$276.00M$147.00M$140.00M$171.00M$159.00M$135.00M$140.00M$134.50M$98.60M$110.30M
Free Cash Flow$379.00M$284.00M$394.00M$131.00M$281.00M$324.00M-$176.00M$84.00M$352.80M$75.20M$45.60M
Shares Outstanding499.55M496.98M494.45M492.85M474.24M473.12M471.92M373.01M365.64Mn/an/a
Weighted Average Diluted Sharesn/a496.40M497.30M492.30M488.30M487.20M441.40M370.30M313.70M293.30Mn/a
EPS (Basic)n/a-$0.47$0.68-$2.50-$0.16-$0.99-$1.30$0.18$0.28-$1.06n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView